Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model

YoungDoo Kim, Hyunwoo Choi, WonJae Lee, Hyejin Park, Tae In Kam, Se hoon Hong, Jihoon Nah, Sunmin Jung, Bora Shin, Huikyong Lee, Tae Yong Choi, Hyosun Choo, Kyung Keun Kim, Se Young Choi, Rakez Kayed, Yong Keun Jung

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

In neurodegenerative diseases like AD, tau forms neurofibrillary tangles, composed of tau protein. In the AD brain, activated caspases cleave tau at the 421th Asp, generating a caspase-cleaved form of tau, TauC3. Although TauC3 is known to assemble rapidly into filaments in vitro, a role of TauC3 in vivo remains unclear. Here, we generated a transgenic mouse expressing human TauC3 using a neuron-specific promoter. In this mouse, we found that human TauC3 was expressed in the hippocampus and cortex. Interestingly, TauC3 mice showed drastic learning and spatial memory deficits and reduced synaptic density at a young age (2-3 months). Notably, tau oligomers as well as tau aggregates were found in TauC3 mice showing memory deficits. Further, i.p. or i.c.v. injection with methylene blue or Congo red, inhibitors of tau aggregation in vitro, and i.p. injection with rapamycin significantly reduced the amounts of tau oligomers in the hippocampus, rescued spine density, and attenuated memory impairment in TauC3 mice. Together, these results suggest that TauC3 facilitates early memory impairment in transgenic mice accompanied with tau oligomer formation, providing insight into the role of TauC3 in the AD pathogenesis associated with tau oligomers and a useful AD model to test drug candidates.

Original languageEnglish (US)
Pages (from-to)19-28
Number of pages10
JournalNeurobiology of Disease
Volume87
DOIs
StatePublished - Mar 1 2016

Fingerprint

Caspases
Transgenic Mice
Memory Disorders
Hippocampus
Congo Red
tau Proteins
Neurofibrillary Tangles
Injections
Methylene Blue
Sirolimus
Neurodegenerative Diseases
Spine
Learning
Neurons
Brain
Pharmaceutical Preparations
In Vitro Techniques

Keywords

  • AD mice
  • Alzheimer's disease
  • Caspase-cleaved tau
  • Tau oligomers
  • Tauopathy

ASJC Scopus subject areas

  • Neurology

Cite this

Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model. / Kim, YoungDoo; Choi, Hyunwoo; Lee, WonJae; Park, Hyejin; Kam, Tae In; Hong, Se hoon; Nah, Jihoon; Jung, Sunmin; Shin, Bora; Lee, Huikyong; Choi, Tae Yong; Choo, Hyosun; Kim, Kyung Keun; Choi, Se Young; Kayed, Rakez; Jung, Yong Keun.

In: Neurobiology of Disease, Vol. 87, 01.03.2016, p. 19-28.

Research output: Contribution to journalArticle

Kim, Y, Choi, H, Lee, W, Park, H, Kam, TI, Hong, SH, Nah, J, Jung, S, Shin, B, Lee, H, Choi, TY, Choo, H, Kim, KK, Choi, SY, Kayed, R & Jung, YK 2016, 'Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model', Neurobiology of Disease, vol. 87, pp. 19-28. https://doi.org/10.1016/j.nbd.2015.12.006
Kim, YoungDoo ; Choi, Hyunwoo ; Lee, WonJae ; Park, Hyejin ; Kam, Tae In ; Hong, Se hoon ; Nah, Jihoon ; Jung, Sunmin ; Shin, Bora ; Lee, Huikyong ; Choi, Tae Yong ; Choo, Hyosun ; Kim, Kyung Keun ; Choi, Se Young ; Kayed, Rakez ; Jung, Yong Keun. / Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model. In: Neurobiology of Disease. 2016 ; Vol. 87. pp. 19-28.
@article{a14f8ecab0ca4f00976ea97cac6180ae,
title = "Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model",
abstract = "In neurodegenerative diseases like AD, tau forms neurofibrillary tangles, composed of tau protein. In the AD brain, activated caspases cleave tau at the 421th Asp, generating a caspase-cleaved form of tau, TauC3. Although TauC3 is known to assemble rapidly into filaments in vitro, a role of TauC3 in vivo remains unclear. Here, we generated a transgenic mouse expressing human TauC3 using a neuron-specific promoter. In this mouse, we found that human TauC3 was expressed in the hippocampus and cortex. Interestingly, TauC3 mice showed drastic learning and spatial memory deficits and reduced synaptic density at a young age (2-3 months). Notably, tau oligomers as well as tau aggregates were found in TauC3 mice showing memory deficits. Further, i.p. or i.c.v. injection with methylene blue or Congo red, inhibitors of tau aggregation in vitro, and i.p. injection with rapamycin significantly reduced the amounts of tau oligomers in the hippocampus, rescued spine density, and attenuated memory impairment in TauC3 mice. Together, these results suggest that TauC3 facilitates early memory impairment in transgenic mice accompanied with tau oligomer formation, providing insight into the role of TauC3 in the AD pathogenesis associated with tau oligomers and a useful AD model to test drug candidates.",
keywords = "AD mice, Alzheimer's disease, Caspase-cleaved tau, Tau oligomers, Tauopathy",
author = "YoungDoo Kim and Hyunwoo Choi and WonJae Lee and Hyejin Park and Kam, {Tae In} and Hong, {Se hoon} and Jihoon Nah and Sunmin Jung and Bora Shin and Huikyong Lee and Choi, {Tae Yong} and Hyosun Choo and Kim, {Kyung Keun} and Choi, {Se Young} and Rakez Kayed and Jung, {Yong Keun}",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.nbd.2015.12.006",
language = "English (US)",
volume = "87",
pages = "19--28",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model

AU - Kim, YoungDoo

AU - Choi, Hyunwoo

AU - Lee, WonJae

AU - Park, Hyejin

AU - Kam, Tae In

AU - Hong, Se hoon

AU - Nah, Jihoon

AU - Jung, Sunmin

AU - Shin, Bora

AU - Lee, Huikyong

AU - Choi, Tae Yong

AU - Choo, Hyosun

AU - Kim, Kyung Keun

AU - Choi, Se Young

AU - Kayed, Rakez

AU - Jung, Yong Keun

PY - 2016/3/1

Y1 - 2016/3/1

N2 - In neurodegenerative diseases like AD, tau forms neurofibrillary tangles, composed of tau protein. In the AD brain, activated caspases cleave tau at the 421th Asp, generating a caspase-cleaved form of tau, TauC3. Although TauC3 is known to assemble rapidly into filaments in vitro, a role of TauC3 in vivo remains unclear. Here, we generated a transgenic mouse expressing human TauC3 using a neuron-specific promoter. In this mouse, we found that human TauC3 was expressed in the hippocampus and cortex. Interestingly, TauC3 mice showed drastic learning and spatial memory deficits and reduced synaptic density at a young age (2-3 months). Notably, tau oligomers as well as tau aggregates were found in TauC3 mice showing memory deficits. Further, i.p. or i.c.v. injection with methylene blue or Congo red, inhibitors of tau aggregation in vitro, and i.p. injection with rapamycin significantly reduced the amounts of tau oligomers in the hippocampus, rescued spine density, and attenuated memory impairment in TauC3 mice. Together, these results suggest that TauC3 facilitates early memory impairment in transgenic mice accompanied with tau oligomer formation, providing insight into the role of TauC3 in the AD pathogenesis associated with tau oligomers and a useful AD model to test drug candidates.

AB - In neurodegenerative diseases like AD, tau forms neurofibrillary tangles, composed of tau protein. In the AD brain, activated caspases cleave tau at the 421th Asp, generating a caspase-cleaved form of tau, TauC3. Although TauC3 is known to assemble rapidly into filaments in vitro, a role of TauC3 in vivo remains unclear. Here, we generated a transgenic mouse expressing human TauC3 using a neuron-specific promoter. In this mouse, we found that human TauC3 was expressed in the hippocampus and cortex. Interestingly, TauC3 mice showed drastic learning and spatial memory deficits and reduced synaptic density at a young age (2-3 months). Notably, tau oligomers as well as tau aggregates were found in TauC3 mice showing memory deficits. Further, i.p. or i.c.v. injection with methylene blue or Congo red, inhibitors of tau aggregation in vitro, and i.p. injection with rapamycin significantly reduced the amounts of tau oligomers in the hippocampus, rescued spine density, and attenuated memory impairment in TauC3 mice. Together, these results suggest that TauC3 facilitates early memory impairment in transgenic mice accompanied with tau oligomer formation, providing insight into the role of TauC3 in the AD pathogenesis associated with tau oligomers and a useful AD model to test drug candidates.

KW - AD mice

KW - Alzheimer's disease

KW - Caspase-cleaved tau

KW - Tau oligomers

KW - Tauopathy

UR - http://www.scopus.com/inward/record.url?scp=84951173131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951173131&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2015.12.006

DO - 10.1016/j.nbd.2015.12.006

M3 - Article

C2 - 26704708

AN - SCOPUS:84951173131

VL - 87

SP - 19

EP - 28

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -